An exploratory investigation of β-aminoisobutyric acid as a biomarker: possible relationships between urinary BAIBA and lifestyle habits Authors: Miu Suzuki, Yuki Shimba, Ayana Sakai, Aika Kobayashi, Sayuri Shibayama, Chika Takahashi, Moe Shibata, Tae Kiyosawa, Yuichiro Obana, Yuhi Yamada, Toshio Hosaka Published: 2026 ABSTRACT AbstractBackgroundβ-Aminoisobutyric acid (BAIBA) is a metabolite of valine and thymine and has been identified as a myokine released from skeletal muscle in response to exercise. Experimental studies have suggested that BAIBA exerts multiple metabolic effects, including promotion of adipose tissue browning and improvement of glucose metabolism. However, evidence regarding BAIBA in humans, particularly its relationships with lifestyle habits, remains unknown, and even the normal plasma range has not been established. We aimed to evaluate plasma and urinary BAIBA excretion in healthy adults and to investigate their associations with lifestyle factors, including physical activity and dietary habits.MethodsFifteen healthy young adults were enrolled in this cross-sectional observational study. Total BAIBA was measured in plasma and one-fiftieth aliquots of 24-h urine samples. Body composition, dietary intake, physical activity, and lifestyle habits were assessed.ResultsPlasma total BAIBA was detectable in only 33% of participants, whereas urinary 24-h total BAIBA calculated by one-fiftieth urine storage of a 24-h urine collection was measurable in all individuals. Participants with detectable plasma BAIBA showed approximately five-fold higher urinary BAIBA excretion than those with undetectable plasma levels [median 1001 vs. 172 μmol/day, p = 0.002]. A higher 24-h urinary BAIBA level was associated with habitually skipping breakfast.ConclusionsIn this small exploratory study, total 24-h urinary BAIBA excretion may reflect systemic BAIBA status more consistently than plasma BAIBA concentration in healthy young adults and appeared to differ according to breakfast-skipping habits. This hypothesis-generating observation should be confirmed in larger studies with adjustment for potential confounders.Keywords: β-aminoisobutyric acid, Total BAIBA, Biomarker, Urinary excretion, Myokine Introduction Beta-aminoisobutyric acid (BAIBA) is a metabolite derived from valine and thymine [1] and has been identified as an exercise-responsive myokine [2]. BAIBA exists as two enantiomers: L-BAIBA/S-BAIBA is mainly derived from valine catabolism, whereas D-BAIBA/R-BAIBA is derived from thymine catabolism [3]. These enantiomers may differ in their physiological roles and baseline distributions. Animal and cell culture studies have demonstrated that BAIBA exerts favorable metabolic effects, including the induction of adipose tissue browning [2], anti-obesity effects [4], or anti-atherosclerotic effects [5]. Despite accumulating molecular evidence, human data on BAIBA are limiting. Previous studies have primarily focused on the plasma levels of BAIBA detectable in hemodialysis patients [6] or after acute exercise [7], or in relation to obesity and exercise training [8]. More recent human studies have also examined BAIBA in the contexts of skeletal muscle contraction, dietary intervention or glucose metabolism [[8], [9], [10]]. Besides the response to physical activity, protein intake or overall dietary patterns might affect plasma S-BAIBA levels, because S-BAIBA is generated through valine catabolism [2]. On the other hand, to our knowledge, limited studies have measured the BAIBA concentrations of individuals with specific lifestyle habits including exercise as well as dietary patterns and food choices. Therefore, evaluating plasma BAIBA levels in relation to lifestyle habits might provide important insights into the physiological relevance of BAIBA metabolism. BAIBA is excreted in urine [1]. However, most human studies have focused on plasma measurements [[6], [7], [8], [9], [10], [11]], urinary BAIBA has also been reported to increase after a dietary intervention in healthy adults [10]. Thus, the physiological significance of urinary BAIBA excretion and its relationship with circulating BAIBA concentrations have not as yet been examined. Moreover, associations between urinary BAIBA levels and lifestyle habits remain to be clarified. Due to the aforementioned limited human evidence, this exploratory investigation aimed to characterize 24-h urinary and plasma BAIBA in healthy adults and to examine their associations with lifestyle habits including the exercise, but not acute exercise, as well as dietary factors such as eating patterns, caloric intake and food choices. By evaluating urinary BAIBA alongside plasma concentrations, this study also sought to clarify whether urinary BAIBA reflects endogenous BAIBA metabolism in daily life and to assess the potential utility of urinary BAIBA as a non-invasive indicator of lifestyle habits. Methods Participants This was a cross-sectional observational study conducted between July 2023 and September 2023. The study was conducted in accordance with the Declaration of Helsinki and was approved by the Research Ethics Committee of the University of Shizuoka (approval number: 4–60). Participant data were anonymized and stored securely in accordance with the institutional regulations of the University of Shizuoka and applicable Japanese data protection requirements. Participants were healthy adults ≥18 years of age with a body mass index (BMI) of 18.5–25.0 kg/m2. Participants were recruited through posters, and participation was entirely voluntary. After receiving a full explanation of the study, written informed consent was obtained from all participants. The exclusion criteria were pregnancy, breastfeeding, using glucose-lowering, antihyperuricemic, antigout, and/or antihypertensive medications, and any history of stroke, cardiovascular disease, or chronic kidney disease. If the investigators deemed a subject inappropriate for participation, due to factors such as illness, that individual was also excluded. This study was designed as an exploratory observational study. Because prior human data on urinary BAIBA excretion and its association with lifestyle habits were not reported, sample size calculation was not performed. Finally, 15 participants were included in the analysis. The characteristics of the 15 participants are presented in Table 1. Eighty percent of the participants were female. The median age was 21.0 (interquartile range [IQR], 19.5–21.5) years, and the median BMI was 19.7 (18.7–21.6) kg/m2. Table 1Characteristics of enrolled participants.Table 1ParametersOverall(n = 15)Male/Female3/12Age (years)21.0 (19.5–21.5)Height (cm)160.3 (154.7–163.2)Body weight (kg)49.5 (48.2–54.9)Body mass index (kg/m2)19.7 (18.7–21.6)Body composition Skeletal muscle mass (kg)20.7 (18.3–24.3) Body fat mass (kg)11.8 (10.6–13.1) Body fat percentage (%)23.4 (21.6–28.3)Dietary intake Energy (kcal/day)1306 (1130–1468) Protein (g/1000 kcal)36.9 (30.8–40.5) Fat (g/1000 kcal)31 (29–36) Carbohydrate (g/1000 kcal)127 (115–147) Dietary Fiber (g/1000 kcal)5.8 (5.1–6.1) Sodium (mg/1000 kcal)2239 (1796–2625) Vitamin B1 (μg/1000 kcal)0.4 (0.3–0.4) Vitamin B2 (μg/1000 kcal)0.6 (0.5–0.7) Vitamin C (μg/1000 kcal)48.3 (34–62.6) Salt equivalent (μg/1000 kcal)5.6 (4.5–6.6)Values are medians (interquartile range). Characteristics of enrolled participants. Values are medians (interquartile range). Measurements Height, body weight, and body composition were determined, and blood samples were collected in the morning after an overnight fast. BMI was calculated from body weight and height. Body composition including skeletal muscle mass, body fat percentage, and mineral content were measured using a bioelectrical impedance analysis with the InBody 770 (InBody Co., Ltd., Korea) [12]. One-fiftieth portions of 24-h urine samples were collected using a portable semiautomatic urine sampling cup (Urinemate P, Sumitomo Bakelite, Japan). This proportional sampling device has been used in previous studies to estimate 24-h urinary excretion of sodium, potassium, and creatinine [13], although it has not been specifically validated for urinary BAIBA. Plasma total BAIBA concentrations were determined by LC/MS at SRL (Tokyo, Japan). Briefly, plasma samples were deproteinized, and free amino acids were derivatized with 3-aminopyridyl-N-hydroxysuccinimidyl carbamate in the HPLC system. The derivatized analytes were separated on an Inertsil ODS-3 column (2.1 × 100 mm; GL Sciences, Tokyo, Japan) and detected by mass spectrometry. The LC/MS system consisted of an LC-20 series HPLC system coupled to an LCMS-2020 mass spectrometer (Shimadzu, Kyoto, Japan). The required plasma volume was 0.5 mL. Urinary total BAIBA excretion was measured by HPLC at SRL, Inc. Amino acids in acidified 24-h urine samples were separated using a strongly acidic cation-exchange resin and reacted with ninhydrin; changes in absorbance were measured at 570 and 440 nm. The HPLC system was a Hitachi L-8500 high-speed amino acid analyzer (Hitachi, Tokyo, Japan) equipped with a 4.6 × 60 mm column for the L-8500 system. The required urine sample volume was 2.0 mL. These analytical methods used in this study did not distinguish between R-BAIBA and S-BAIBA; therefore, all BAIBA values were interpreted as total BAIBA. Then, urinary total BAIBA during a 24-h period was calculated employing urinary BAIBA multiplied by 50. Physical activity for one month was determined using a triaxial accelerometer (Active style Pro, Omron, Japan) [14]. Nutritional intake was assessed using the brief-type self-administered diet history questionnaire (BDHQ), a validated semi-quantitative food frequency questionnaire designed to estimate habitual dietary intake during the preceding month [15]. Lifestyle habits including exercise, dietary behaviors and weight gain were assessed using a standardized questionnaire developed by the Ministry of Health, Labour and Welfare, Japan [16]. The parameters assessed as representing lifestyle habits were regular exercise (≥30 min, ≥2 times/week, ≥1 year), walking or equivalent physical activity (≥1 h/day), fast walking speed [yes/no], eating speed (fast/normal/slow), eating within 2 h before bedtime (≥3 times/week), snacking outside the three main meals (≥3 times/week), or skipping breakfast (≥3 times/week). The questionnaire was using the questions, “Have you engaged in exercise that causes light sweating with at least 30 min per session of two or more times per week for at least 1 year?” Daily physical activity was assessed using the question, “Do you walk or engage in equivalent physical activity for at least 1 h per day?” Late-night dinner was assessed using the question, “Do you eat dinner within 2 h before bedtime three or more times per week?” Bedtime snacking was assessed using the question, “Do you eat snacks after dinner three or more times per week?” Breakfast skipping was assessed using the question, “Do you skip breakfast three or more times per week?” Statistical analysis Plasma total BAIBA was analyzed as a dichotomous variable (detectable or undetectable), because a substantial proportion of participants had plasma total BAIBA levels below the detection limit (66%, n = 10). Hartigan's dip test was performed as an exploratory analysis to assess whether the distribution of 24-h urinary total BAIBA excretion deviated from unimodality. No established cutoff value for urinary BAIBA excretion is available, participants were classified into lower and higher urinary total BAIBA groups using a data-driven exploratory cutoff. The cutoff was defined as the midpoint of the largest gap in the observed distribution of estimated 24-h urinary total BAIBA excretion. This grouping was used only for exploratory comparisons. Two-group comparisons of continuous variables were performed using the Mann-Whitney U test. Comparisons of categorical variables were performed using Fisher's exact test, and correlations were assessed using Spearman's rank correlation coefficient. P-values were adjusted using the Benjamini–Hochberg false discovery rate (FDR) method. Hartigan's dip test was conducted to test unimodality of urinary total BAIBA excretion. A two-sided p-value <0.05 was considered to indicate a statistically significant association. Data are presented as medians (interquartile ranges). All statistical analyses were performed using EZR [17]. Results Plasma total BAIBA concentrations of only five participants were quantified, because those of the remaining ten participants (66%) were below the quantification limit (3 μM). Twenty-four-hour urinary total BAIBA excretion was measurable in all participants. Hartigan's dip test suggested deviation from unimodality in 24-h urinary total BAIBA excretion (p = 0.010). For these exploratory comparisons, participants were classified into lower and higher urinary total BAIBA groups using a data-driven cutoff, defined as the midpoint of the largest gap in the observed distribution. The cutoff was 537 μmol/day. Median urinary total BAIBA excretion differed substantially between the higher and lower groups (987 μmol/day vs. 140 μmol/day; Fig. 1). In addition, participants with detectable plasma total BAIBA exhibited approximately five-fold higher urinary BAIBA excretion than those without detectable plasma total BAIBA (1001 μmol/day vs. 172 μmol/day, p = 0.002) (Fig. 2). Distribution of estimated 24-h urinary total BAIBA excretion. Comparison between subjects with detectable or undetectable plasma and urinary BAIBA excretion The data are presented as a box plot. Based on this finding and the limited detectability of plasma total BAIBA, subsequent analyses focused on urinary total BAIBA excretions. The association between urinary total BAIBA excretion and parameters related to body composition or physical activity within 2 weeks before visiting, were analyzed, as BAIBA functioning as a myokine was already described in the “Introduction section”. There were no significant differences in muscle-related parameters nor any form of physical activity between the two groups (Table 2, Table 3). Table 2Comparison between low and high urinary BAIBA groups in terms of body composition, physical activity, exercise habits, dietary intake, and dietary habits.Table 2ParametersOverall (n = 15)Low urinary BAIBA group (n = 8)High urinary BAIBA group (n = 7)PQUrinary BAIBA excretion (μmol/day)219 (140-984)140 (60-197)987 (950-1126)--Muscle Mass (kg)36.4 (32.3-41.5)36.5 (31.7-43.8)36.4 (34.7-37.4)0.8671.000Skeletal muscle mass (kg)20.7 (18.3-24.3)21 (18-25.8)20.7 (19.8-21.5)0.8671.000Body fat percentage (%)23.4 (21.6-28.3)24.1 (21-28.6)23.4 (22-26.7)0.8671.000 Walking exercise within 2 weeks before (Mets.hours/day)3.9 (3.4-4.5)3.8 (3.4-4.1)4.0 (3.3-4.6)0.8671.000 Household exercise within 2 weeks before (Mets.hours/day)1.7 (1.3-2)1.8 (1.6-1.9)1.6 (1-2)0.6131.000 Moderate-vigorous physical activity within 2 weeks before (Mets.hour/day)5.3 (5-6.7)5.2 (5.1-6.7)5.4 (5.1-6.3)0.9551.000Exercise and physical activity habits Regular exercise (≥30 min,≥2 times/week, ≥1 year)4 [26.7]3 [37.5]1 [14.3]0.5691.000 Walking or equivalent physical activity ≥1 h/day9 [60.0]5 [62.5]4 [57.1]1.0001.000 Fast walking speed3 [20.0]1 [12.5]2 [28.6]0.3541.000Body weight gain (>10 kg) from 20 years old3 [20.0]0 [0.0]3 [42.9]0.0760.988Dietary intake Energy (kcal)1306 (1130-1468)1189 (983-1294)1137 (869-1361)1.0001.000 Protein (g/1000 kcal)36.9 (30.8-40.5)31.9 (29.8-41.1)38.9 (35.7-40.2)0.6131.000 Fat (g/1000 kcal)31 (29-36)30.1 (29.3-31.8)35.1 (30.1-37.1)0.4631.000 Carbohydrate (g/1000 kcal)127 (115-147)128 (115-147)121 (115-142)0.9551.000 Dietary fiber (g/1000 kcal)5.8 (5.1-6.1)5.7 (5.3-6)5.9 (5.1-6.1)0.9551.000 Sodium (mg/1000 kcal)2239 (1796-2625)2426 (1833-2622)2068 (1777-2494)0.7791.000 Vitamin B1 (μg/1000 kcal)0.4 (0.3-0.4)0.3 (0.3-0.4)0.4 (0.3-0.4)1.0001.000 Vitamin B2 (μg/1000 kcal)0.6 (0.5-0.7)0.6 (0.5-0.6)0.6 (0.6-0.7)0.1891.000 Niacin (μg/1000 kcal)7.8 (6.9-10.4)7.7 (6.6-10.6)7.8 (7.4-10)0.9551.000 Vitamin B6 (μg/1000 kcal)0.6 (0.5-0.7)0.6 (0.5-0.8)0.6 (0.5-0.6)1.0001.000 Vitamin B12 (μg/1000 kcal)3.3 (2.2-5)2.8(2.1-6.1)3.5(2.4-3.9)0.9551.000 Pantothenic acid (μg/1000 kcal)3.5 (3-3.8)3.1 (2.9-3.4)3.8 (3.6-3.9)0.1211.000Eating habits Eating speed Fast3 [20.0]1 [12.5]2 [28.6]0.7651.000 Normal10 [66.7]6 [75.0]4 [57.1] Slow2 [13.3]1 [12.5]1 [14.3]Eating within 2 h before bedtime7 [46.7]3 [37.5]4 [57.1]0.6191.000Snacking4[26.7]2 [25.0]2 [28.6]1.0001.000Breakfast skipping5 [33.3]0 [0.0]5 [71.4]0.0060.156Data are presented as a median (interquartile range) or number [%]. Statistical analyses were conducted using the Mann-Whitney U test or Fisher's exact test. Q-values were calculated using the Benjamini–Hochberg false discovery rate method. Comparison between low and high urinary BAIBA groups in terms of body composition, physical activity, exercise habits, dietary intake, and dietary habits. Data are presented as a median (interquartile range) or number [%]. Statistical analyses were conducted using the Mann-Whitney U test or Fisher's exact test. Q-values were calculated using the Benjamini–Hochberg false discovery rate method. Table 3Spearman's rank correlation between urinary total BAIBA excretion and physical activity variables within 2 weeks before the visit.Table 3Parametersrs (95%CI)PHousehold exercise within 2 weeks before (Mets.hours/day)−0.049 (−0.611 to 0.583)0.873Moderate-vigorous physical activity within 2 weeks before (Mets.hour/day)0.209 (−0.406 to 0.824)0.494Walking exercise within 2 weeks before (Mets.hours/day)0.115 (−0.499 to 0.661)0.707Values are presented as Spearman's rank correlation coefficients (rs), 95% confidence intervals (CI), and p-values. Spearman's rank correlation between urinary total BAIBA excretion and physical activity variables within 2 weeks before the visit. Values are presented as Spearman's rank correlation coefficients (rs), 95% confidence intervals (CI), and p-values. Also, because S-BAIBA is a metabolite of valine, the relationships between urinary total BAIBA excretion and dietary intake factors including the energy compositions of foods and the amounts of nutritional ingredients, as well as eating habits, were analyzed. Participants in the higher urinary total BAIBA group were associated with breakfast skipping (p = 0.006); however, this finding did not remain statistically significant after Benjamini–Hochberg FDR correction (FDR-adjusted q = 0.210) (Table 2). Breakfast-skipping status substantially overlapped with plasma total BAIBA detectability. Indeed, one participant who eat breakfast had detectable plasma total BAIBA, whereas one participant who skip breakfast had undetectable plasma total BAIBA. Discussion We analyzed total BAIBA in 24-h urine and plasma samples, as well as their relationships with body composition, physical activity, nutritional intake, and lifestyle habits. Consequently, plasma total BAIBA concentrations were below the detection limit in most participants, whereas BAIBA was detectable in 24-h urine samples from all participants. In addition, urinary total BAIBA levels were higher in participants with detectable plasma BAIBA, and the high-urinary total BAIBA group showed a nominal association with skipping breakfast. This difference between urinary and plasma BAIBA detection raises the possibility that BAIBA is difficult to detect in plasma due to low circulating that may be close to the quantification limit of this assay, or that BAIBA is readily detectable in urine during a 24-h collection period, due to BAIBA usually being secreted in very small amounts into plasma, in normal states, as a downstream metabolite of amino acid and nucleotide metabolism [3]. Previous human studies reported that plasma BAIBA concentration in nanomolar to low micromolar range. For example, baseline plasma R-BAIBA and S-BAIBA concentration were 1734 nM and 29.3 nM, respectively [7]. Another research reported that BAIBA concentration during exercise is around 3 μM [9]. Indeed, oral administration of BAIBA (170 mg/kg body weight) increases the level to approximately 3.4 μM plasma BAIBA in mouse models [5] with only a limited proportion of administered BAIBA remaining in the bloodstream. However, non-absorbed BAIBA was not considered in that study. The prior report might support the notion of rapid systemic clearance of BAIBA, but their results could not be directly extrapolated to humans. Taking prior studies together, we can reasonably suggest that plasma BAIBA concentrations in healthy humans are very low, often in the nanomolar to low micromolar range, depending on the enantiomer and analytical method, and that urinary BAIBA may be a more detectable matrix than plasma BAIBA under the present analytical conditions. However, this suggestion is limiting that direct pharmacokinetic data on the renal handling of BAIBA have not been reported, and the physiological significance of urinary BAIBA requires further investigation. No significant association was observed between physical activity and 24-h urinary total BAIBA excretion. Previous studies have shown acute exercise to increase plasma BAIBA concentrations by approximately 0.25 μM, corresponding to about 15% of baseline plasma BAIBA levels [7], i.e., levels reportedly in the micromolar-range in vivo [2,5]. Therefore, habitual physical activity, particularly at lower intensity, may have been insufficient to substantially influence 24-h urinary total BAIBA excretion in the present study. However, this negative finding should also be interpreted in light of the measurement characteristics of this study. Because we measured total BAIBA and not BAIBA enantiomers, urinary total BAIBA excretion may partly reflect non-exercise-related metabolic pathways, including thymine/pyrimidine catabolism, rather than exercise-responsive BAIBA release from skeletal muscle [7,11]. In addition, the small sample size and the lack of detailed assessment of high-intensity exercise may have contributed to the lack of association. Future studies using enantiomer-specific BAIBA measurements and exercise intervention designs are needed to clarify whether urinary BAIBA reflects exercise-related BAIBA metabolism in humans. Urinary total BAIBA excretion showed a nominal relationship with breakfast skipping in the unadjusted exploratory analysis; however, this finding was not significant after FDR correction. In addition, breakfast-skipping status substantially overlapped with plasma total BAIBA detectability, although the classifications were not identical. Therefore, the observed relationship between breakfast skipping and urinary total BAIBA excretion cannot be interpreted as an independent association with dietary behavior. Moreover, because this study measured total BAIBA without distinguishing between BAIBA enantiomers, we could not determine whether the observed pattern reflected valine-derived BAIBA metabolism, thymine/pyrimidine catabolism, or other nucleotide metabolism-related processes. Thus, the finding between urinary total BAIBA excretion and breakfast skipping should be interpreted as hypothesis-generating. This study has several limitations. First, it was an exploratory analysis with a small sample size and multiple comparisons, which limited statistical power and increased the risk of false-positive findings. Second, the detection limit for plasma BAIBA concentrations was relatively high (3 μM), which may have contributed to the low detection rate. Third, the analytical methods used in this study measured total BAIBA and did not distinguish between R-BAIBA and S-BAIBA. Because these enantiomers have distinct metabolic origins and may differ in their physiological roles, we could not determine whether the observed urinary BAIBA patterns were mainly related to valine-derived metabolism, thymine/pyrimidine catabolism, or other nucleotide metabolism-related processes. Fourth, because of the cross-sectional design of this study, causal relationships cannot be established, and reverse causation and unmeasured confounding cannot be excluded. Fifth, dietary intake and lifestyle habits were assessed using self-administered questionnaires, which may be affected by recall bias, social desirability bias, and misclassification. Fasting duration and meal timing were not objectively measured. Sixth, estimated 24-h urinary total BAIBA excretion was calculated from one-fiftieth aliquots of 24-h urine collection. So this proportional sampling method has not been specifically validated for total urinary BAIBA. Lastly, the participants were highly homogeneous, mainly young women, which limits the generalizability of the findings. Further studies are needed to clarify the renal handling and physiological relevance of urinary BAIBA. In conclusion, this exploratory study evaluated 24-h urinary and plasma total BAIBA concentrations in healthy individuals. We also examined relationships with lifestyle habits. BAIBA was detectable in all 24-h urine samples, whereas plasma concentrations were frequently below the detection limit. Urinary total BAIBA levels might reflect plasma total BAIBA status. Twenty-four-hour urinary total BAIBA excretion was not associated with either physical activity or body composition but was associated with skipping breakfast. These findings suggested that urinary total BAIBA might be related to metabolic states associated with meal timing. Further studies, larger in scale, are warranted to clarify the physiological and clinical relevance of urinary BAIBA levels in humans. CRediT authorship contribution statement Miu Suzuki: Data curation, Formal analysis, Investigation, Writing – review & editing. Yuki Shimba: Conceptualization, Data curation, Funding acquisition, Investigation, Project administration, Supervision, Writing – original draft, Writing – review & editing. Ayana Sakai: Investigation, Writing – review & editing. Aika Kobayashi: Investigation, Writing – review & editing. Sayuri Shibayama: Investigation, Writing – review & editing. Chika Takahashi: Investigation, Writing – review & editing. Moe Shibata: Investigation, Writing – review & editing. Tae Kiyosawa: Investigation, Writing – review & editing. Yuichiro Obana: Investigation, Writing – review & editing. Yuhi Yamada: Investigation, Writing – review & editing. Toshio Hosaka: Conceptualization, Data curation, Funding acquisition, Supervision, Writing – review & editing. Declaration of competing interest The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Acknowledgement This work was supported by JSPS KAKENHI Grant Numbers JP22K21210, and Lotte Research. Promotion Grant. The funding bodies had no role in the study conception or design, participant recruitment, data collection, data analysis, data interpretation, manuscript preparation, or the decision to submit the manuscript for publication. Data availability Data will be made available on request. References Associated Data Data Availability Statement Data will be made available on request.